The characteristics of TRIB2 structure and signal transduction and its role in many cancer subtypes focus on the function of TRIB2 in the therapeutic resistance of melanoma, leukemia, and glioblastoma (Mayoral-Varo et al., 2021). This evidence concerns the gene TRIB2 and melanoma.